Cellular uptake and cytotoxicity of modified chitosans as gene carriers

Acta Academiae Medicinae Sinicae

Volumn 28, Issue 4, 2006, Pages 486-491

  Zhang, Hai Ling ^a   Zhu, Dun Wan ^a,b   Yang, Jian ^a,b   Song, Li Ping ^a   Bo, Jin Gen ^a,b   Yao, Kang De ^a,b   Leng, Xi Gang ^a  

^a INSTITUTE OF BIOMEDICAL ENGINEERING   (China)

^b TIANJIN UNIVERSITY   (China)

Author keywords

Cellular uptake; Chemical modification; Chitosan; Cytotoxicity; Nanoparticle complex

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ARGININE DERIVATIVE; CHITOSAN DERIVATIVE; DEOXYADENOSINE TRIPHOSPHATE; LIPOFECTAMINE; NANOPARTICLE; PLASMID DNA;

ARTICLE; CELL ASSAY; CELL TRANSPORT; COACERVATION; CONTROLLED STUDY; CYTOTOXICITY; IN VITRO STUDY; LIQUID SCINTILLATION COUNTING; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PARTICLE SIZE; PROTEIN MODIFICATION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ZETA POTENTIAL;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; ARGININE; CHITOSAN; CITRIC ACID; CYTOTOXICITY, IMMUNOLOGIC; DNA; GENETIC VECTORS; NANOPARTICLES; RATS;

EID: 33749868068     PISSN: 1000503X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Chinese source. 2005, 22(6):1171-1176.
2. Choi JS, Nam K, Park JY. et al. Enhanced transfection efficiency of PAMAM dendrimer by surface modification with 1-arginine. J Controlled Release, 2004, 99(3):445-456.
3. Liu WG, Yao KD, Liu QG. Formation of a DNA/N-Dodecylated chitosan complex and salt-induced gene delivery. J Appl Polym Sci, 2001, 82(14):3391-3395.
4. Liu WG, Zhang JR, Cao ZQ, et al. A chitosan-arginine conjugate as a novel anticoagulation biomaterial. J Mater Sci Mater Med, 2004, 15(11):1199-1203.
5. Mao HQ, Roy K, Troung-Le VL, et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Controlled Release, 2001, 70(3):399-421.
6. Liu W, Sun S, Cao Z, et al. An investigation on the physicochemical properties of chitosan/DNA polyelectrolyte complexes. Biomaterials, 2005, 26(15):2705-2711.
7. Ozgel G, Akbuga J. In vitro characterization and transfection of IL-2 gene complexes. Int J Pharm, 2006, 315(1-2):44-51.
8. Mahato RI. Water insoluble and soluble lipids for gene delivery. Adv Drug Deliv Rev, 2005, 57(5):699-712.
9. Prabha S, Zhou WZ, Panyam J. et al. Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int J Pharm, 2002, 244(1-2):105-115.
10. Köping-Höggard M, Varum KM, Issa M. Improved-chitosan mediated-gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Ther, 2004, 11(19):1441-1452.
11. Liu WG, Zhang X, Sun SJ, et al. N-alkylated chitosan as a potential nonviral vector for gene transfection. Bioconjugate Chem, 2003, 14(4):782-789.
12. Ishii T, Okahata Y, Sato T. Mechanism of cell transfection with plasmid/ chitosan complexes. Biochim Biophys Acta, 2001, 1514(1):51-64.
13. Bozkir A, Saka OM. Chitosan-DNA nanoparticles: effect on DNA integrity, bacterial transformation and transfection efficiency. J Drug Target, 2004, 12(5):281-288.
14. Huang M, Khor E, Lim LY. UptAke and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. Pharm Res, 2004, 21(2):344-353.
15. Fischer D, Li Y, Ahlemeyer B. et al. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials, 2003, 24(7):1121-1131.
16. Ewert K, Ahmad A, Evans HM. et al. Efficient synthesis and cell-transfection properties of a new multivalent cationic lipid for nonviral gene delivery. J Med Chem, 2002, 45(23):5023-5029.
17. Corsi K, Chellat F, Yahia L, et al. Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials, 2003, 24(7):1255-1264.
18. Mansouri S, Lavigne P, Corsi K, et al. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. Eur J Pharm Biopharm, 2004, 57 (1):1-8.